ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
19.99
-0.16 (-0.79%)
At close: May 12, 2025, 4:00 PM
20.50
+0.51 (2.55%)
After-hours: May 12, 2025, 4:24 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $680.56 million as of May 12, 2025. Its market cap has increased by 32.80% in one year.
Market Cap
680.56M
Enterprise Value
504.62M
1-Year Change
32.80%
Ranking
Category
Stock Price
$19.99
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $680.56M, an increase of 18.31%. That is a compound annual growth rate of 13.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 686.01M | -23.58% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |